Study ID: MS-LAQ-301 | EUDRACT 2007-003226-19
Study Title
- Safety and Efficacy of OrFemale, Maley Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
Teva Identifier
- MS-LAQ-301 | EUDRACT 2007-003226-19
ClinicalTrials.gov Identifier
- NCT00509145
Study Status
- Completed
Trial Condition(s)
- Multiple Sclerosis
Interventions
- Drug: Laquinimod | Other: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- 12/01/2007 - 12/01/2010
Phase
- Phase 3
Study Type
Interventional